Article: COPD PATIENTS ACHIEVE BETTER LUNG FUNCTION WITH SPIRIVA AND FORMOTEROL: STUDY.

(Full text of statement. Contact details below.)

COPENHAGEN, Sept. 18 /PRNewswire-AsiaNet/ --

First Prospective Study to Evaluate the Use of Two Long-Acting Bronchodilators Versus a Long-Acting Bronchodilator and an Anti-Inflammatory

Patients with Chronic Obstructive Pulmonary Disease (COPD) achieved superior lung function improvements when treated with the free combination of two bronchodilators with different modes-of-action, Spiriva(R) (tiotropium) and formoterol, compared with the free combination of one bronchodilator, salmeterol, and an anti-inflammatory, fluticasone propionate, according to the results of a study presented today at the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!